Abstract: It is intended to develop and provide a method for detecting a particular glycan-isoform rapidly and specifically by a small number of steps. The present invention provides a glycan-isoform detection method comprising quantifying an immune complex formed by the mixing of a test sample with a sugar chain non-reducing terminal residue-binding lectin and an antibody specifically binding to the protein moiety of the glycan-isoform, etc., comparing the obtained amount of the immune complex with the amount of a control immune complex obtained when a control sample is not mixed with the sugar chain non-reducing terminal residue-binding lectin or is mixed with a control protein, and determining the presence or absence of the glycan-isoform of interest in the test sample on the basis of the difference between these amounts.

Abstract: An image forming apparatus includes an image holding body, a developing device, a transfer device, a collection device, a container, and a transport member. The image holding body includes a surface on which a latent image is formed. The developing device develops the latent image into a visual image with developer. The transfer device transfers the visual image onto a transfer medium. The collection device collects the developer remaining on the surface of the image holding body after the visual image has been transferred. The container contains new developer supplied to the developing device. The image forming apparatus has a channel that has a first sub-channel and a second sub-channel. The developer flows into the first sub-channel from one of the collection device and the container and the second sub-channel from the other of the collection device and the container.

Abstract: An image forming apparatus includes an image holding body, a developing device, a transfer device, a collection device, a container, and a transport member. The image holding body includes a surface on which a latent image is formed. The developing device develops the latent image into a visual image with developer. The transfer device transfers the visual image onto a transfer medium. The collection device collects the developer remaining on the surface of the image holding body after the visual image has been transferred. The container contains new developer supplied to the developing device. The image forming apparatus has a channel that has a first sub-channel and a second sub-channel. The developer flows into the first sub-channel from one of the collection device and the container and the second sub-channel from the other of the collection device and the container.

Abstract: A developing device includes a developer container including a first chamber and a second chamber arranged along a lateral direction, which crosses a gravitational direction, developer circulating through the first chamber and the second chamber; a transporting member rotatably disposed in the first chamber; and a supply member rotatably disposed in the second chamber. A lower end position of the supply member and a lower end position of the transporting member in the gravitational direction are at the same level. While the supply member and the transporting member are rotating, an upper surface of developer contained in the first chamber and an upper surface of developer contained in the second chamber are at levels not higher than an upper end position of the transporting member but not lower than an upper end position of the supply member in the gravitational direction.

Abstract: It is intended to develop and provide a method for detecting a particular glycan-isoform rapidly and specifically by a small number of steps. The present invention provides a glycan-isoform detection method comprising quantifying an immune complex formed by the mixing of a test sample with a sugar chain non-reducing terminal residue-binding lectin and an antibody specifically binding to the protein moiety of the glycan-isoform, etc., comparing the obtained amount of the immune complex with the amount of a control immune complex obtained when a control sample is not mixed with the sugar chain non-reducing terminal residue-binding lectin or is mixed with a control protein, and determining the presence or absence of the glycan-isoform of interest in the test sample on the basis of the difference between these amounts.

Abstract: A developing device includes a developer container including a first chamber and a second chamber arranged along a lateral direction, which crosses a gravitational direction, developer circulating through the first chamber and the second chamber; a transporting member rotatably disposed in the first chamber; and a supply member rotatably disposed in the second chamber. A lower end position of the supply member and a lower end position of the transporting member in the gravitational direction are at the same level. While the supply member and the transporting member are rotating, an upper surface of developer contained in the first chamber and an upper surface of developer contained in the second chamber are at levels not higher than an upper end position of the transporting member but not lower than an upper end position of the supply member in the gravitational direction.

Abstract: Disclosed is an agent for improving at least one activity selected from the group consisting of the growth activity, adhesion activity and extension activity of mesenchymal stem cells, which comprises laminin-5 as an active ingredient. A method of culturing mesenchymal stem cells; a method of isolating mesenchymal stem cells; and a medium, vessel or sheet for use in culturing mesenchymal stem cells are also provided.

Abstract: Disclosed is an agent for improving at least one activity selected from the group consisting of the growth activity, adhesion activity and extension activity of mesenchymal stem cells, which comprises laminin-5 as an active ingredient. A method of culturing mesenchymal stem cells; a method of isolating mesenchymal stem cells; and a medium, vessel or sheet for use in culturing mesenchymal stem cells are also provided.

Abstract: A non-magnetic toner having a single main ingredient without a carrier has two toner components having different mean grain sizes. The small-size toner component has a lower resistivity than the resistivity of the large-size toner component to achieve a stable mount of electrified charge and thus an excellent image quality during the printing using the toner.

Abstract: An electrostatically charged image is applied to a smooth surface and moved past a development zone in which a carrier sheet perforated with a multitude of bores is also located. A layer of developing liquid is applied under gradually increasing pressure to a first surface of the carrier sheet so that the applied liquid squeezes through the bores to and beyond a second, opposite surface of the carrier sheet. The liquid emerges above the opposite surface of the carrier sheet to produce a multitude of part-spherical bulges. Field concentration occurs on the part-spherical surfaces of the individual tiny bulges. The first surface of the carrier sheet preferably exhibits lyophilic characteristic to the developing liquid, while the second surface exhibits lyophobic characteristic.